Suresh K Verma

4.6k total citations
82 papers, 2.6k citations indexed

About

Suresh K Verma is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Suresh K Verma has authored 82 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 23 papers in Cardiology and Cardiovascular Medicine and 11 papers in Obstetrics and Gynecology. Recurrent topics in Suresh K Verma's work include Extracellular vesicles in disease (14 papers), Cardiac Fibrosis and Remodeling (14 papers) and MicroRNA in disease regulation (8 papers). Suresh K Verma is often cited by papers focused on Extracellular vesicles in disease (14 papers), Cardiac Fibrosis and Remodeling (14 papers) and MicroRNA in disease regulation (8 papers). Suresh K Verma collaborates with scholars based in United States, India and Japan. Suresh K Verma's co-authors include Raj Kishore, Prasanna Krishnamurthy, Prabhat Ranjan, Venkata Naga Srikanth Garikipati, Gangjian Qin, Sumanta Goswami, Erin Lambers, Asish K. Ghosh, Alexander R Mackie and Douglas W. Losordo and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Suresh K Verma

79 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suresh K Verma United States 31 1.4k 652 558 383 239 82 2.6k
Tao Zeng China 30 1.1k 0.8× 311 0.5× 519 0.9× 175 0.5× 308 1.3× 151 2.6k
Ning Hou China 31 1.9k 1.3× 369 0.6× 585 1.0× 260 0.7× 190 0.8× 116 3.0k
Lei Yu China 27 990 0.7× 307 0.5× 630 1.1× 372 1.0× 111 0.5× 140 2.4k
Qing Song China 26 1.1k 0.8× 226 0.3× 336 0.6× 509 1.3× 192 0.8× 95 2.6k
Xiang Zhou China 28 1.6k 1.1× 622 1.0× 1.0k 1.8× 210 0.5× 210 0.9× 75 3.1k
Xin Yi China 28 1.4k 1.0× 333 0.5× 675 1.2× 279 0.7× 200 0.8× 122 2.6k
Suresh C. Tyagi United States 37 1.7k 1.2× 930 1.4× 733 1.3× 462 1.2× 245 1.0× 129 3.9k
Carmen C. Sucharov United States 30 1.6k 1.2× 910 1.4× 543 1.0× 265 0.7× 111 0.5× 96 2.6k
Soyeon Lim South Korea 29 1.2k 0.9× 294 0.5× 368 0.7× 546 1.4× 205 0.9× 104 2.6k
Xi‐Yong Yu China 28 2.1k 1.5× 721 1.1× 1.0k 1.8× 552 1.4× 404 1.7× 85 3.6k

Countries citing papers authored by Suresh K Verma

Since Specialization
Citations

This map shows the geographic impact of Suresh K Verma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suresh K Verma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suresh K Verma more than expected).

Fields of papers citing papers by Suresh K Verma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suresh K Verma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suresh K Verma. The network helps show where Suresh K Verma may publish in the future.

Co-authorship network of co-authors of Suresh K Verma

This figure shows the co-authorship network connecting the top 25 collaborators of Suresh K Verma. A scholar is included among the top collaborators of Suresh K Verma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suresh K Verma. Suresh K Verma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ranjan, Prabhat, Sumanta Goswami, Harish C. Pal, et al.. (2025). Hypertrophic heart failure promotes gut dysbiosis and gut leakage in interleukin 10-deficient mice. American Journal of Physiology-Heart and Circulatory Physiology. 328(3). H447–H459. 3 indexed citations
2.
Sinha, Adrija, Aditya Nandi, Nirmal Kumar Mohakud, et al.. (2025). Translational paradigm in nanodiagnostics applications of functionalized zinc oxide nanoforms interface for pathogenic virus diagnostics. Chemical Engineering Journal. 509. 161260–161260. 4 indexed citations
3.
Nandi, Aditya, et al.. (2024). Intrinsic physiochemical insights to green synthesized Ag-decorated GO nanosheet for photoluminescence and in vivo cellular biocompatibility with embryonic zebrafish. Colloids and Surfaces B Biointerfaces. 245. 114212–114212. 5 indexed citations
4.
Ranjan, Prabhat, et al.. (2021). mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification. Cardiovascular Research. 118(7). 1680–1692. 143 indexed citations
5.
Goswami, Sumanta, et al.. (2021). Management of inflammation in cardiovascular diseases. Pharmacological Research. 173. 105912–105912. 77 indexed citations
6.
Gupta, Rajesh, Lijun Liu, Xiaolu Zhang, et al.. (2020). IL-10 provides cardioprotection in diabetic myocardial infarction via upregulation of Heme clearance pathways. JCI Insight. 5(17). 23 indexed citations
7.
Yue, Yujia, Venkata Naga Srikanth Garikipati, Suresh K Verma, David A. Goukassian, & Raj Kishore. (2017). Interleukin-10 Deficiency Impairs Reparative Properties of Bone Marrow-Derived Endothelial Progenitor Cell Exosomes. Tissue Engineering Part A. 23(21-22). 1241–1250. 41 indexed citations
8.
Sharma, Chanderdeep, Anjali Soni, Aditya K. Gupta, Ashok Verma, & Suresh K Verma. (2017). Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial. American Journal of Obstetrics and Gynecology. 217(6). 687.e1–687.e6. 25 indexed citations
9.
Nagpal, Varun, Rahul Rai, Aaron T. Place, et al.. (2016). MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis. Circulation. 133(3). 291–301. 196 indexed citations
10.
Verma, Suresh K, et al.. (2016). Abstract 19530: Cardiac Fibroblasts Derived Exosomes Enhanced Endothelial to Mesenchymal Transition and Associated Fibrotic Signaling. Circulation. 1 indexed citations
11.
Verma, Suresh K, Venkata Naga Srikanth Garikipati, Prasanna Krishnamurthy, et al.. (2016). IL-10 Accelerates Re-Endothelialization and Inhibits Post-Injury Intimal Hyperplasia following Carotid Artery Denudation. PLoS ONE. 11(1). e0147615–e0147615. 27 indexed citations
12.
Cheng, Zhongjian, Venkata Naga Srikanth Garikipati, Emily Nickoloff, et al.. (2016). Restoration of Hydrogen Sulfide Production in Diabetic Mice Improves Reparative Function of Bone Marrow Cells. Circulation. 134(19). 1467–1483. 48 indexed citations
13.
Verma, Ashok, et al.. (2016). A study on cervical cancer screening in symptomatic women using Pap smear in a tertiary care hospital in rural area of Himachal Pradesh, India. Middle East Fertility Society Journal. 22(1). 39–42. 31 indexed citations
14.
Joladarashi, Darukeshwara, Venkata Naga Srikanth Garikipati, Rajarajan A. Thandavarayan, et al.. (2015). Enhanced Cardiac Regenerative Ability of Stem Cells After Ischemia-Reperfusion Injury. Journal of the American College of Cardiology. 66(20). 2214–2226. 60 indexed citations
17.
Kishore, Raj & Suresh K Verma. (2012). Roles of STATs signaling in cardiovascular diseases. PubMed. 1(2). 118–124. 43 indexed citations
18.
Lal, Hind, Suresh K Verma, Hao Feng, et al.. (2012). Caveolin and β1-integrin coordinate angiotensinogen expression in cardiac myocytes. International Journal of Cardiology. 168(1). 436–445. 5 indexed citations
19.
Verma, Ashok, et al.. (2011). FETOMATERNAL OUTCOME FOLLOWING POSTDATE PREGNANCY : A PROSPECTIVE STUDY. 1(3). 7 indexed citations
20.
Verma, Suresh K, et al.. (2009). Colposcopic assessment of the cervix using the simplified Reid's Colposcopic Index method. Current Science. 96(3). 386–391. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026